IBCResearch Profile Banner
IBC Research Fdn Profile
IBC Research Fdn

@IBCResearch

Followers
2K
Following
35K
Media
1K
Statuses
14K

Web-based, all volunteer non-profit working to improve the lives of those touched by inflammatory breast cancer (IBC) through the power of advocacy & action.

Broadway, VA 22815
Joined August 2013
Don't wanna be here? Send us removal request.
@IBCResearch
IBC Research Fdn
13 days
Stats for BC aren't very reliable. They're often based on a single institution (could look overly optimistic) or SEER data, which might show the opposite. These data aren't current so understand that YOU are not a statistic. My prognosis was 12-18 mo. That was 31 years ago!
0
0
1
@IBCResearch
IBC Research Fdn
15 days
As #pinkoctober winds down, I hope you've learned the importance of paying attention to your body, that not all breast cancer has a lump and evidence-based treatment is needed when dealing with cancer. Learn more at https://t.co/6C7S6iZjnZ
0
2
4
@IBCResearch
IBC Research Fdn
16 days
Thank you @stage4kelly for helping educate about #IBC / #Inflammatorybreastcancer
@stage4kelly
Dr. Kelly Shanahan
18 days
Not all breast cancer starts with a lump. IBC is aggressive and deserves more research.
0
1
2
@stage4kelly
Dr. Kelly Shanahan
22 days
It is long past the time when people should be excluded from trials due to brain mets. Did you know that brain metastasis is more common than primary brain tumors?
@metavivor
METAvivor
23 days
Brain metastases are usually diagnosed by MRI. When cancer spreads to the meninges or cerebrospinal fluid, it’s called leptomeningeal disease—a particularly difficult form to treat. We need more research—and trials that include people with brain mets. #UntilNoOneDiesFromMBC
0
4
18
@IBCResearch
IBC Research Fdn
21 days
Tylenol Maker Fights Autism Warning Label, Citing Lack of Scientific Evidence
Tweet card summary image
empr.com
The maker of Tylenol is urging the FDA to reject autism warning requests for the drug's use in pregnancy.
0
0
0
@IBCResearch
IBC Research Fdn
22 days
Before 'standard of care' for #IBC survival was 12-18 mo. Since then, we've learned that #chemofirst works best for aggressive breast cancers like #IBC. Speak up if your doctor suggests surgery first....or find a new treatment team!!
0
0
1
@OncoAlert
OncoAlert
25 days
DESTINY Breast 05 presented at #ESMO25 Study breakdown T-DXd-THP in high-risk HER2+ 🧬early #BreastCancer Results mirrored Breast11 — a pCR rate of 67% vs 56% and a favorable safety profile with less grade ≥3 toxicity and less cardiotoxicity. @matteolambe @aftimosp
0
16
26
@OncoAlert
OncoAlert
25 days
ASCENT 03 presented at #ESMO25 Study breakdown In #TNBC #BreastCancer , the ASCENT-03 trial assessed sacituzumab govitecan in previously untreated patients ineligible for PD-1 or PD-L1 inhibitors. The ADC improved progression-free survival from 6.9 to 9.7 months, with more
0
13
23
@weoncologists
Gil Morgan, MD
1 month
NEWS FROM Industry: HER2CLIMB-05 Update Source: Pfizer announcement, report by Business wire OncoAlert 🚨
@OncoAlert
OncoAlert
1 month
NEWS FROM Industry: HER2CLIMB-05 Update Source: Pfizer announcement, report by Business wire https://t.co/P75uFNuhpI Pfizer announced positive topline results from the Phase 3 HER2CLIMB-05 trial, which evaluated the addition of the tyrosine kinase inhibitor tucatinib to
1
4
28
@tmprowell
Tatiana Prowell, MD
25 days
📣 In 68K women in 🇺🇸 case-control studies in CARRIERS consortium: those w/ pathogenic mutation plus a 1st degree relative w/ #breastcancer had 23% risk of BC by age 50 & 51% risk from age 50-80 (vs 9% & 30% for those w/ just a mutation). Esp striking w/ PALB2. #bcsm #MedTwitter
@SidYadavMD
Sid Yadav MD, FACP
25 days
We are excited to share results from our recently published article in @JAMAOnc In this study of 67,692 U.S. women, we identify that carriers of germline pathogenic variants in BRCA1, BRCA2, ATM, CHEK2 and PALB2 and a first-degree family history of breast cancer had a higher risk
1
6
20
@IBCResearch
IBC Research Fdn
24 days
It's hard to advocate 4 yourself, u need to learn first! Visit https://t.co/6C7S6iZRdx for info & experience with #IBC direct them to https://t.co/3rLqbY5GEo for guidelines developed by physicians for physicians. (check out the patient guide they offer as well) #Youareworthit
0
1
2
@IBCResearch
IBC Research Fdn
26 days
Oct 16 was #NationalMammogramDay. While they can be useful, they seldom pick up #IBC. Don't let a Dr dismiss your concerns just because they didn't see a lump. YOU know your body, so keep pushing for answers. #AdvocateforYourself
0
1
3
@IBCResearch
IBC Research Fdn
26 days
Largest evacuation in recent memory underway after devastating Alaska flooding https://t.co/Um66xgnJjN Our hearts go out to these folks in #Alaska...can only imagine their challenges now and in the coming weeks.
0
0
2
@double_whammied
Double Whammy
1 month
7% of physicians say the #priorauth requirements in health insurance contribute to their patients' deaths. Remind me again why we have health insurance at all?
@fumikochino
Fumiko Ladd Chino, MD, FASCO
1 month
@double_whammied Yes we presented our work at #ASCOQLTY25 yesterday showing that 7% of physicians said that #priorAuth contributed to patient death
0
1
3
@OncoAlert
OncoAlert
28 days
Dear Colleagues at #ESMO25 An honor to introduce our @OncoAlert 🚨Faculty @delmastro_lucia 🇮🇹 discussing the results of #monarchE 🦋 in #BreastCancer Presentati a #ESMO25 i risultati aggiornati dello studio monarchE che dimostrano come abemaciclib nel trattamento adiuvante
1
17
25
@IBCResearch
IBC Research Fdn
29 days
Last year I shared there was no IBC specific ICD code making it hard to obtain accurate #s of ppl dx with IBC. Thanks to efforts of the #IBCCollaborative, we made that happen! Share this info with HCPs & don't forget to tell them about the #IBC Diagnostic Scoring Scale as well!
0
0
0